• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非镉污染地区日本一般人群的肾小管功能障碍与癌症死亡率。

Renal tubular dysfunction and cancer mortality in the Japanese general population living in cadmium-non-contaminated areas.

机构信息

Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

Department of Hygiene, Kanazawa Medical University, Uchinada, Japan.

出版信息

J Appl Toxicol. 2022 Sep;42(9):1458-1466. doi: 10.1002/jat.4304. Epub 2022 Mar 3.

DOI:10.1002/jat.4304
PMID:35181909
Abstract

The relationship between cadmium exposure, exposure-related renal tubular dysfunction, and mortality have been reported, mainly in the residents of Cd-contaminated areas in Japan. The aim of this study was to establish the cause-effect relationship between renal tubular dysfunction and cancer mortality in the general population in non-contaminated areas. A 19-year cohort study was conducted in 1110 men and 1703 women in 1993 or 1994, who lived in three cadmium-non-contaminated areas. Mortality risk ratios of urinary β2-microglobulin (β2MG) and N-acetyl-β-glucosaminidase (NAG) for all malignant neoplasms and specific cancers were estimated using the Fine and Gray competing risks regression model. Significant hazard ratios (HRs) for liver and pancreas cancer were observed for NAG (liver: HR corresponding to an increase of 1 IU/g cr, 1.10, 95%CI, 1.02-1.19, pancreas: HR, 1.10, 95%CI, 1.02-1.19) in men. In women, a negative HR was observed for NAG (lung cancer: HR 0.80, 95% CI, 0.67-0.96) and for β2MG (all malignant neoplasms: HR, 0.97, 95% CI, 0.93-1.00). The present study indicated that renal tubular dysfunction was significantly related to mortality in the general population of cadmium-non-contaminated areas in Japan.

摘要

镉暴露、与暴露相关的肾小管功能障碍与死亡率之间的关系已被报道,主要是在日本镉污染地区的居民中。本研究旨在确定非污染地区普通人群肾小管功能障碍与癌症死亡率之间的因果关系。对 1993 年或 1994 年居住在三个无镉污染地区的 1110 名男性和 1703 名女性进行了一项为期 19 年的队列研究。使用 Fine 和 Gray 竞争风险回归模型估计尿β2-微球蛋白 (β2MG) 和 N-乙酰-β-氨基葡萄糖苷酶 (NAG) 的所有恶性肿瘤和特定癌症的死亡率风险比。对于男性,NAG(肝:对应于 1 IU/g cr 增加的 HR,1.10,95%CI,1.02-1.19,胰腺:HR,1.10,95%CI,1.02-1.19)对肝癌和胰腺癌的危险比(HR)有显著意义。对于女性,NAG(肺癌:HR 0.80,95%CI,0.67-0.96)和β2MG(所有恶性肿瘤:HR,0.97,95%CI,0.93-1.00)呈负 HR。本研究表明,在日本无镉污染地区的普通人群中,肾小管功能障碍与死亡率显著相关。

相似文献

1
Renal tubular dysfunction and cancer mortality in the Japanese general population living in cadmium-non-contaminated areas.非镉污染地区日本一般人群的肾小管功能障碍与癌症死亡率。
J Appl Toxicol. 2022 Sep;42(9):1458-1466. doi: 10.1002/jat.4304. Epub 2022 Mar 3.
2
Effect of renal tubular damage on non-cancer mortality in the general Japanese population living in cadmium non-polluted areas.居住在镉非污染地区的普通日本人群中肾小管损伤对非癌症死亡率的影响。
J Appl Toxicol. 2023 Dec;43(12):1849-1858. doi: 10.1002/jat.4518. Epub 2023 Jul 17.
3
Renal tubular dysfunction increases mortality in the Japanese general population living in cadmium non-polluted areas.肾小管功能障碍会增加生活在镉无污染地区的日本普通人群的死亡率。
J Expo Sci Environ Epidemiol. 2015 Jul-Aug;25(4):399-404. doi: 10.1038/jes.2014.44. Epub 2014 Jun 18.
4
Relationship between urinary β -microglobulin concentration and mortality in a cadmium-polluted area in Japan: A 35-year follow-up study.日本镉污染地区尿 β-微球蛋白浓度与死亡率的关系:一项 35 年随访研究。
J Appl Toxicol. 2021 Feb;41(2):224-232. doi: 10.1002/jat.4038. Epub 2020 Jul 15.
5
N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas.N-乙酰-β-D-氨基葡萄糖苷酶(NAG)作为监测无污染地区居民肾小管功能障碍最敏感的标志物。
Toxicol Lett. 2009 Oct 8;190(1):1-8. doi: 10.1016/j.toxlet.2009.05.009. Epub 2009 May 23.
6
Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.基于日本镉未污染地区总蛋白、β2-微球蛋白和N-乙酰-β-D-氨基葡萄糖苷酶的排泄情况,将基准剂量估算为尿镉的阈值水平。
Environ Res. 2006 Jul;101(3):401-6. doi: 10.1016/j.envres.2005.12.002. Epub 2006 Jan 24.
7
Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas.镉暴露减少后肾功能的变化:镉污染地区居民的 8 年随访研究。
Environ Health Perspect. 2012 Feb;120(2):223-8. doi: 10.1289/ehp.1103699. Epub 2011 Oct 25.
8
Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand.泰国人群的风险评估:通过泰国污染和未污染地区居民的混合方法确定肾脏效应的尿镉和血镉水平基准剂量。
BMC Public Health. 2014 Jul 9;14:702. doi: 10.1186/1471-2458-14-702.
9
Effects of aging on cadmium concentrations and renal dysfunction in inhabitants in cadmium-polluted regions in Japan.日本镉污染地区居民的年龄对镉浓度和肾功能障碍的影响。
J Appl Toxicol. 2017 Sep;37(9):1046-1052. doi: 10.1002/jat.3455. Epub 2017 Mar 6.
10
Health effects of cadmium exposure in the general environment in Japan with special reference to the lower limit of the benchmark dose as the threshold level of urinary cadmium.日本一般环境中镉暴露对健康的影响,特别提及作为尿镉阈值水平的基准剂量下限。
Scand J Work Environ Health. 2005 Aug;31(4):307-15. doi: 10.5271/sjweh.887.

引用本文的文献

1
Carcinogenesis Associated with Toxin Nephropathy: Proposed Mediation by Phosphate Toxicity.与毒素性肾病相关的致癌作用:磷酸盐毒性介导作用的探讨
Cells. 2025 Jun 22;14(13):952. doi: 10.3390/cells14130952.
2
Isolation and characterization of cadmium-resistant strains from Cd-contaminated mining areas for potential bioremediation applications.从镉污染矿区分离和鉴定耐镉菌株以用于潜在的生物修复应用。
Front Microbiol. 2025 Feb 12;16:1550830. doi: 10.3389/fmicb.2025.1550830. eCollection 2025.
3
Toxicity Tolerance in the Carcinogenesis of Environmental Cadmium.
环境镉致癌过程中的毒性耐受
Int J Mol Sci. 2024 Feb 3;25(3):1851. doi: 10.3390/ijms25031851.
4
Cadmium body burden and health effects after restoration of cadmium-polluted soils in cadmium-polluted areas in the Jinzu River basin.在津祖河流域镉污染地区,受镉污染土壤修复后,体内镉负荷与健康影响。
Environ Health Prev Med. 2023;28:49. doi: 10.1265/ehpm.23-00132.